Effect of budesonide, montelukast and their combination in allergic rhinitis

Phase 2

Recruiting

• Conditions: Allergic rhinitis.; Vasomotor and allergic rhinitis

• Registration Number: IRCT20171030037093N41
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 November 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 135

Inclusion Criteria

Having allergic rhinitis
Age over 15 years

Exclusion Criteria

smoking
Pregnancy
Asthma
Nasal polyps
Severe nasal deviation
Nasal tumor or mass
Sinusitis
Get any treatment for allergic rhinitis within a week before the visit
Existence of severe underlying disease
Having Churg-Strauss

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Runny nose score. Timepoint: Before intervention, 3 weeks, 6 weeks and 12 weeks after treatment. Method of measurement: Visual Analogue Scale and Sino-nasal Outcome Test questionnaires.;Sneezing score. Timepoint: Before intervention, 3 weeks, 6 weeks and 12 weeks after treatment. Method of measurement: Visual Analogue Scale and Sino-nasal Outcome Test questionnaires.;Nasal congestion score. Timepoint: Before intervention, 3 weeks, 6 weeks and 12 weeks after treatment. Method of measurement: Visual Analogue Scale and Sino-nasal Outcome Test questionnaires.;Itchy nose score. Timepoint: Before intervention, 3 weeks, 6 weeks and 12 weeks after treatment. Method of measurement: Visual Analogue Scale and Sino-nasal Outcome Test questionnaires.